|
European Journal of General Medicine, Vol. 6, No. 3, July-September, 2009, pp. 154-160 Article Vitamin E protects against oxidative damage caused by cadmium in the blood of rats Mehmet Kanter1 , Burhan Aksu2 , Meryem Akpolat1 , Yeter Topcu Tarladacalisir1 , Cevat Aktas1 , Hamdi Uysal 3 1 Department of Histology & Embryology, Faculty of Medicine, Trakya University, Edirne, Turkey Code Number: gm09034 Abstract Aim: The protective effect of vitamin E (vit E) on cadmium (Cd) induced oxidative stress was studied in the blood of rats. Methods: The rats were randomly divided in to three experimental groups: Control, Cd treated and Cd + vit E treated, each containing 10 animals. The Cd treated and Cd + vit E treated groups were injected subcutaneously daily with CdCl2 dissolved in isotonic NaCl in the amount of 2 mL/kg for 20 days, resulting in a dosage of 0.49 mg Cd/kg/d. In addition, Cd + vit E treated group received intramuscular injection of 150 mg/kg vit E until the end of the study. Results: Cd treatment increased significantly malondialdehyde (MDA) levels and the antioxidant enzyme activities of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and catalase (CAT) in plasma and erythrocytes compared to the control group. Cd + vit E treatment, decreased significantly elevated MDA levels in plasma and erythrocyte and also reduced significantly the enhanced antioxidant levels. Cd treatment increased significantly the activity of iron levels in the plasma compared to the control group. Cd + vit E treatment, decreased the activity of iron levels in the plasma compared to the Cd treated group. In the control group, the histology of erythrocytes was normal. In Cd treated group, there was marked membrane destruction and there were hemolytic changes in erythrocytes. In Cd + vit E treated group, these changes were less than Cd treated group. Conclussion: Our results show that vit E exerts a protective effect against cadmium toxicity.Keywords: Vitamin E, cadmium, hemolysis, oxidative stress, blood, rat Introduction Cadmium (Cd) is a wide-spread environmental pollut-ant, characterized by its toxicity to various organs, including kidney, liver, lung, testis, brain, bone, blood system [1],[2],[3] . The molecular mechanisms of its toxic-ity are not yet well defined. Cd has been demon-strated to stimulate free radical production, resulting in oxidative deterioration of lipids, proteins and DNA, and initiating various pathological conditions in hu-mans and animals [4],[7] . After the intake and resorp-tion, Cd enters the blood where it binds to the red blood cell (RBC) membranes and plasma albumin [8]. In the blood and tissues, Cd stimulates the formation of metallothioneins [9] and reactive oxygen species (ROS) thus causing oxidative damage in RBCs and in various tissues, which result in a loss of membrane functions [10] . Cd also induces the onset of anemia, decreases the RBC count, hemoglobin concentration and hematocrit value as well as producing reduced blood iron levels [11]. Moreover, a variety of ac-companying changes in antioxidant defense enzymes were reported [12],[13]. Fariss [14] has shown that free radical scavengers and antioxidants are useful in protecting against Cd toxicity. Vit E protects critical cellular structures against dam-age caused by oxygen free radicals and reactive products of lipid peroxidation. It has been reported that lipid peroxidation is prevented by vit E [15] . Vit E inhibits peroxidation of membrane lipids by scavenging lipid peroxyl radicals, as a consequence of which it is converted into a tocopheroxyl radical. In fact, α-tocopherylquinone may act as a potent an-ticoagulant and as an antioxidant through its reduc-tion to hydroquinone [16]. Also, Boldyrev et al [17] reported that the protective role of vit E against the toxicity of oxidants may be due to the quenching of hydroxyl radicals. The aim of this study was to investigate a possible protective effect of vit E treatment on the selected biochemical parameters and histological changes of RBCs in rat exposed to Cd. Material and Methods Animals Thirty healthy male Wistar albino rats, weighing 200-250 g and averaging 16 weeks old were supplied from The Center of Medical Investigations of Yuzuncu Yil University. The animals were given standard rat pel-lets (Murat animal food product co., Ankara, Turkey) and tap water ad libitum. The rats were house singly in temperature controlled (20-25°C) cages. They were housed in macrolon cages under standard labo-ratory conditions (light period 7.00 a.m. to 7.00 p.m., 21±2°C, relative humidity 55%). Treatment of Rats The rats were randomly divided in to three experi-mental groups: A (Control), B (Cd treated) and C (Cd + vit E treated), each containing 10 animals. The Cd treated and Cd + vit E treated groups injected subcutaneously daily with CdCl2 dissolved in isotonic NaCl in the amount of 2ml/kg for 20 days, resulting in a dosage of 0.49 mg Cd/kg/d [18]. The control groups were injected with only isotonic NaCl (2 mL/ kg/d) throughout the experiment. In addition, the Cd + vit E treated group received intramuscular injection of 150 mg/kg/d Vit E (Evigen, Turkey) until the end of the study. All animals received care according to the criteria outlined in the "Guide for the Care and Use of Laboratory Animals" prepared by the National Academy of Sciences and published by the National Institutes of Health. At the end of the experiment, blood samples were obtained for biochemical and histopathological in-vestigations. The rats in all groups were starved overnight for 12 h, and sacrificed under ketamine hydrocloride (Ketalar® , Eczacibbasi Farma 10 mg/kg i.p.) anaesthesia. Blood from the heart was collected from the abdominal and thoracic cavities into potassium-EDTA tubes using 10 ml syringes (10.5 mg/7 mL). Blood samples were centrifuged at 3000 rpm for 5 minutes in a refrigerated centrifuge and the Plasma and buffy coat were discarded. Packed RBCs were washed twice with normal saline after 1/10 dilution to remove remaining leukocytes and plasma components. All reagents were of analyti-cal grade. Trichloroacetic acid (TCA), 2-thiobarbituric acid (TBA) and hexane were purchased from Merck Chemical Company, Darmstadt, Germany. n-Heptane and α-α'dipyridyl were purchased from Sigma (St Louis, USA). Biochemical Analysis Malondialdehyde (MDA) was determined by the dou-ble heating method of Draper and Hadley [19]. This method is based on the fact that lipid peroxides and TBA react to form a pink pigment with absorption maximum at 532 nm. For this purpose, 2.5 mL of 100 g/L TCA solution were added to 0.5 mL hemolysate/ plasma in each centrifuge tube and placed in a boiling water-bath for 15 min. After cooling in tap water, the mixture was centrifuged at 1000 g for 10 min, and 2 mL of the supernatant was added to 1 mL of 0.67% (w/v) TBA solution in a test tube and placed in a boiling water-bath for 15 min. The solution was then cooled in tap water and its absorbance was measured using a Shimadzu UV-1601 (Japan) spec-trophotometer at 532 nm. The concentration of MDA was calculated by the absorbance coefficient of MDA-TBA complex, 1.56 Χ 105 cm-1 M-1, and is expressed in nmol/g hemoglobin (Hb) and in plasma nmol/mL. All samples were assayed in duplicate. Blood for the determination of antioxidant status was centrifuged to separate plasma and RBCs. Isolated RBCs were washed three times with 3 volumes of ice-cold 155 mmol/L NaCl and hemolysates containing about 50g Hb/L prepared according to McCord and Fridovich [20] were used for the determination of catalase (CAT) and glutathione peroxidase (GSH-Px) activities. CAT activity was determined according to Beutler, [21] while the activity of GSH-Px was as-sayed by the subsequent oxidation of NADPH at 340 nm with t-buthyl-hydroperoxide as a substrate [22]. For determination of superoxide dismutase (SOD) by the method of Misra and Fridovich, [23] lysates were diluted with distilled water (1:7 v/v) and treated by chloroform-ethanol (0.6:1 v/v) in order to remove hemoglobin. The clinical chemical analysis of plasma was performed on a Cobas integra 800 automatic analyzer of Roche Diagnostic (USA). Analysis of blood was carried out at 37°C with potassium-EDTA plasma. Analysis of iron was done according to the instruc-tions of the manufacturer of the automatic analyzer. Hb measurement was by mixing blood with Drabkin solution, which contains potassium ferricyanide and potassium cyanide. Morphological Evaluation Blood samples using sterile potassium-EDTA tubes. Immediately after mixing with blood by inverting the tubes, blood-smears were made by spreading one drop on a slide and then stained with the Giemsa solution. RBCs morphology was determined using a Nikon Optiphot-2 microscope (Tokyo, Japan) with an oil immersion 100/1.25 objective. Image Analysis The system we used consisted of a PC with hardware and software (Image-Pro Plus 5.0-Media Cybernetics, USA) for image acquisition and analysis, Spot Insight QE (Diagnostic Instruments, USA) camera and optical microscope. The method requires preliminary soft-ware procedures of spatial calibration (micron scale) and setting of color segmentation for quantitative color analysis. The image analysis program was used for morphologic evaluation of the samples. Twenty areas from each group were chosen randomly. The number of intact and hemolysed RBCs were mea-sured. The investigators who performed these mea-surements were unaware of the experiment. Statistical Analysis The data were expressed as mean ± standard devia-tion (SD) and analysed using repeated measures of variance. Tukey test was used to test for differences among means when ANOVA indicated a significant (p< 0.05) F ratio. Results Plasma MDA, and RBC MDA, SOD, GSH-Px and CAT were presented in [Table - 1]. As shown in [Table - 1], Cd treatment increased significantly MDA levels in plasma and RBC (p< 0.01) and also increased signifi-cantly the antioxidant levels (SOD, GSH-Px and CAT) (p< 0.01) compared to the control group. Vit E treat-ment decreased significantly elevated MDA levels in plasma and RBC (p< 0.05) and also reduced signifi-cantly the enhanced antioxidant levels (p< 0.05). As shown in [Table - 2], Cd treatment increased sig-nificantly the activity of iron levels (p< 0.05) in the plasma compared to the control group. Vit E treat-ment decreased the activity of iron levels (p< 0.05) in the plasma compared to the Cd treated group. It was found that the RBC counts decreased (p< 0.05) in Cd treated rats. Vit E treatment increased (p< 0.05) the lowered RBC counts. It was also found that the hemolysed RBC counts increased (p< 0.001) in Cd treated rats. Vit E treatment reduced (p< 0.01) hemo-lysed RBC counts number [Table - 3]. In control group, histology of RBCs was normal [Figure - 1]. In Cd treated group, there were remarkable mem-brane destruction and hemolytic changes in RBCs [Figure - 2]. In Cd + vit E treated group, these changes were less than Cd group [Figure - 3]. Discussion Cd is a toxic metal that is widely used in different industries. It promotes an early oxidative stres and afterward contributes to the development of serious pathological conditions because of its long reten-tion in some tissues [24]. The present results have clearly demonstrated the ability of Cd to induce oxidative stress in rat plasma and RBC as evidenced by increased lipid peroxidation after 20 days of Cd treatment. This finding is in agreement with sev-eral reports demonstrating that Cd induces oxidative stress in tissues by increasing lipid peroxidation and by altering the antioxidant status in several tissues [4],[5],[6],[25]. RBC membrane is rich in polyunsaturated fatty acids which are very susceptible to free radical mediated peroxidation. Membrane to induce lipid peroxidation and eventually cause hemolysis [26]. Lipid peroxidation is associated with a wide variety of toxicological effects, including decreased mem-brane fluidity and function, impaired mitochondrial and Golgi apparatus functions, and inhibition of en-zymes. MDA is an end product of lipid peroxidation and is a frequently measured index of these process-es. MDA can croos-link with membrane constituents of RBC [27],[28]. The deformability of destructed RBC and increased RBC hemolysis may be due to increased production of free radicals. It has been shown that parenteral ap-plication of α-tocopherol caused a marked decrease in lipid peroxidation in the RBC membrane on chronic hemodialysis patients [29]. In our study, we found that the administration of vit E decreased RBC MDA levels significantly as compared to Cd treated group. Previous investigations showed that chronic treatment with Cd induced oxidative damage in RBCs of rats and goldfish, causing destruction of cell membranes and increased lipid peroxidation, as well as alteration of the antioxidant defence system, energy metabo-lism and the appearance of anemia [11],[25],[30],[31],[32],[33],[34]. The data of other authors showed that Cd caused the damage of the RBC membrane resulting in hemolysis. Some antioxidants can exert a protective role against Cd-induced destruction of RBCs [7]. Treatment with Cd increased lipid peroxide concen-tration in the blood of rats which was accompanied by increased formation of ROS [6],[35]. As a conse-quence, enhanced lipid sulfhydryl homeostasis as well as marked disturbances of antioxidant defence system occurred [36],[38]. Pretreatment with vitamin E exhib-ited a protective role on the toxic effects of Cd on the hematological values, lipid peroxide concentra-tion as well as on enzymatic and non-enzymatic com-ponents of antioxidant defence system [34]. In our study, Cd treatment increased significantly MDA levels in plasma and RBC compared to the control group. Cd + vit E treatment decreased significantly elevated MDA levels in plasma and RBC. These findings sup-ported by El-Demerdash et al [39] who reported that treatment of vitamin E with CdCl2 produces a sig-nificant reduction in CdCl2-induced increase in TBARS in different rat tissues. This finding is paralleled by modulation of GST in plasma and liver. As a conse-quence of ameliorated oxidative stress and ROS, the activities of plasma, liver, testes and brain enzymes were partially restored. Thus, the present results in-dicate that adequate antioxidant status may attenu-ate Cd-induced oxidative stress and cellular damage. Activities of SOD, CAT and GSH-Px were significantly increased in RBC of Cd- treated rats. It is known that Cd induces the formation of superoxide anion radicals in RBCs and it is reasonable to expect an increased activity of SOD [11],[25],[33],[34],[37]. Cd induced an in-crease in CAT and GSH-Px activities which may be explained by their influence on hydrogen peroxide as substrate which is formed in the process of dismuta-tion of superoxide anion radicals [7]. The pretreat-ment with vit E prior to Cd administration decreased RBC SOD, CAT and GSH-Px activities indicating that Vit E eliminates the toxic effects of Cd on the activ-ity of these enzymes [34]. Our result is in accordance with a recent report of Kanter et al [25] who showed that Cd treatment increased significantly the antioxi-dant levels (SOD, GSH-Px and CAT) in plasma and RBC compared to the control group. Cd + Nigella sativa treatment decreased significantly elevated antioxi-dant levels in plasma and RBC. In contrast, Sarkar et al [6] indicated that the RBC SOD and CAT activities decreased significantly with Cd and the pretreatment with vit E and/or selenium prior to Cd administration partially reversed these changes. In addition, Beytut et al [40] observed that the Cd treatment decreased the GSH-Px activity of RBC. Armutcu et al. [41] demonstrated that plasma iron levels were significantly increased in the acetone-treated rats. It has been suggested that this in-creasing might be associated with hemolysis in the RBCs. Increasing of plasma iron levels reflect the rise in hemolysis of RBCs. Iron concentration of plasma is elevated in hemolysis due to iron of haemoglo-bin [42]. Our previous investigation showed that Cd treatment increased significantly the activity of iron levels in the plasma compared to the control group. Cd + Nigella sativa treatment decreased the activ-ity of iron levels in the plasma compared to the Cd treated group [25]. Similar to these results our pres-ent data show that Cd causes significant increase of iron levels. But cotreatment of rats with Cd and vit E combination caused a significant decrease the levels of iron. However, Kostic et at [11] indicated that the chronic exposure of Cd decreases the level of iron in the blood and causes the decrease of the RBC count, hemoglobin concentration and hematocrit value. The decrease of hematocrit value in hemolyzed plasma of rats exposed to Cd indicates the increased destruc-tion of RBCs [43],[44]. It was found in this work that the RBC counts decreased in Cd treated rats. Vit E treatment increased the lowered RBC counts. It was also found that the hemolysed RBC counts increased in Cd treated rats. Vit E treatment reduced hemo-lysed RBC counts number. It can be concluded from presented results that Cd induced oxidative damage in RBCs leads to anemia, loss of membrane function by enhancing of lipid peroxide concentration as well as alteration of the activity of antioxidant defense system enzymes. Our results show that vit E expressed protective role against toxic influence of Cd on all examined param-eters in rat blood. References
Copyright 2009 - European Journal of General Medicine The following images related to this document are available:Photo images[gm09034f2.jpg] [gm09034f1.jpg] [gm09034t3.jpg] [gm09034t2.jpg] [gm09034f3.jpg] [gm09034t1.jpg] |
|